Micro-Tech (Nanjing) Co., Ltd. (688029.SS) Bundle
Dig into Micro-Tech Co., Ltd. (688029.SS) and you'll find a firm posting a Q3 revenue of 815.16 million CNY (up 20.12% year-over-year) and a TTM revenue of 3.12 billion CNY (+16.61% YoY) while 2024 revenue reached 2.76 billion CNY (+14.26%), supported by a 67.65% gross margin in 2024 and steady quarterly growth; profitability reads strong too, with TTM net income at 611.40 million CNY (net margin 19.57%), 2024 parent-net profit of 551.67 million CNY (+13.53%), operating margin of 20.48% and TTM EPS of 3.26 CNY, cash generation is robust-TTM operating cash flow 708.89 million CNY and free cash flow 451.56 million CNY-while balance sheet strength shows total debt of 246.33 million CNY, cash & equivalents of 2.21 billion CNY for a net cash position of 1.96 billion CNY, debt-to-equity of 0.06 and an interest coverage ratio of 158.59; valuation metrics include a trailing P/E of 24.09, forward P/E 21.82, P/S 4.70 and P/B 3.46, market cap stands at 14.68 billion CNY with enterprise value 12.89 billion CNY, and growth vectors-overseas revenue +30.4% in 2024 with region splits showing APAC +5.5%, Americas +23.5% and EMEA +37.1%-make for a data-rich profile worth unpacking in detail.
Micro-Tech Co., Ltd. (688029.SS) Revenue Analysis
Micro-Tech (Nanjing) Co., Ltd. reported continued top-line expansion through 2024 and into 2025, with notable quarter and TTM gains that reflect both volume and pricing strength.- Q3 (ending Sep 30, 2025) revenue: 815.16 million CNY (+20.12% YoY).
- TTM revenue (as of Sep 30, 2025): 3.12 billion CNY (+16.61% YoY).
- FY 2024 revenue: 2.76 billion CNY (+14.26% YoY).
- Revenue per share (TTM ending Sep 2025): 16.65 CNY.
- Quarterly revenue growth (as of Mar 31, 2025): +12.80% QoQ.
- Gross profit margin (2024): 67.65% (improvement of 3.15 percentage points YoY).
| Metric | Value | Period | Change |
|---|---|---|---|
| Quarter Revenue | 815.16 million CNY | Q3 2025 (ending Sep 30, 2025) | +20.12% YoY |
| TTM Revenue | 3.12 billion CNY | TTM to Sep 30, 2025 | +16.61% YoY |
| FY Revenue | 2.76 billion CNY | FY 2024 | +14.26% YoY |
| Revenue per Share | 16.65 CNY | TTM to Sep 30, 2025 | - |
| Quarterly Revenue Growth | +12.80% | As of Mar 31, 2025 | QoQ |
| Gross Profit Margin | 67.65% | FY 2024 | +3.15 ppt YoY |
- Consistent YoY revenue expansion across FY 2024 and the first three quarters of 2025 supports upward revenue per share (16.65 CNY TTM).
- High gross margin (67.65% in 2024) indicates strong product mix or pricing power that helped translate sales growth into durable profitability improvements.
- Robust quarterly acceleration (+12.80% QoQ as of Mar 31, 2025) suggests recent operational momentum entering the latter half of 2025.
Micro-Tech Co., Ltd. (688029.SS) - Profitability Metrics
- Net income (TTM ending 2025-09-30): 611.40 million CNY; net profit margin: 19.57%.
- Net profit attributable to parent (2024): 551.67 million CNY - +13.53% year-over-year.
- Operating margin (2024): 20.48%, reflecting efficient operational management.
- Return on equity (ROE) (TTM ending 2025-03-31): 15.76%.
- Earnings per share (EPS) (TTM ending 2025-09-30): 3.26 CNY.
- Operating cash flow materially exceeds capital expenditures - strong cash conversion from earnings.
| Metric | Value | Period |
|---|---|---|
| Net income | 611.40 million CNY | TTM ending 2025-09-30 |
| Net profit margin | 19.57% | TTM ending 2025-09-30 |
| Net profit attributable to parent | 551.67 million CNY | 2024 (YoY +13.53%) |
| Operating margin | 20.48% | 2024 |
| ROE | 15.76% | TTM ending 2025-03-31 |
| EPS | 3.26 CNY | TTM ending 2025-09-30 |
| Operating cash flow vs CapEx | Operating cash flow >> CapEx | Most recent reporting periods |
- Profitability profile: high operating margin (20.48%) aligns with net margin (19.57%), indicating limited non-operating drag.
- ROE of 15.76% suggests effective equity deployment supporting shareholder returns.
- EPS of 3.26 CNY and rising net profit (2024 +13.53%) point to improving per-share earnings power.
- Strong operating cash flow relative to capital expenditures supports reinvestment and dividend/repayment capacity.
Micro-Tech Co., Ltd. (688029.SS) - Debt vs. Equity Structure
Micro-Tech Co., Ltd. (688029.SS) presents a conservative leverage profile with a debt-to-equity ratio of 0.06 as of the latest reported period, reflecting minimal reliance on external debt financing relative to equity.- Total debt: 246.33 million CNY
- Cash and cash equivalents: 2.21 billion CNY
- Net cash position: 1.96 billion CNY (cash minus debt)
- Debt-to-equity ratio (latest): 0.06
- Five-year debt-to-equity trend: increased from 0% to 4.5%
- Interest coverage ratio: 158.59
- Operating cash flow debt coverage: 371.4%
- Short-term assets vs. short-term liabilities: 3.5 billion CNY vs. 863.8 million CNY
| Metric | Value |
|---|---|
| Total debt | 246.33 million CNY |
| Cash & cash equivalents | 2.21 billion CNY |
| Net cash | 1.96 billion CNY |
| Debt-to-equity ratio (current) | 0.06 |
| Debt-to-equity ratio (5 years ago) | 0% |
| Debt-to-equity ratio (latest 5-year) | 4.5% |
| Interest coverage ratio | 158.59 |
| Operating cash flow coverage of debt | 371.4% |
| Short-term assets | 3.5 billion CNY |
| Short-term liabilities | 863.8 million CNY |
- Low leverage: a debt-to-equity of 0.06 signals limited financial risk from debt.
- Strong liquidity buffer: net cash of ~1.96 billion CNY and short-term assets comfortably exceed short-term liabilities.
- Exceptional interest coverage (158.59) indicates operating earnings vastly exceed interest obligations.
- High operating cash flow coverage (371.4%) shows cash generation is ample to service and repay debt.
- Trend note: leverage has risen from 0% to 4.5% over five years - still conservative but worth monitoring for future capital structure shifts.
Micro-Tech Co., Ltd. (688029.SS) - Liquidity and Solvency
Micro-Tech's balance sheet and cash-flow metrics point to a conservative liquidity posture and strong solvency cushions, supported by robust cash generation and minimal near-term interest burden. Key figures below illustrate the company's capacity to meet short-term obligations and fund operations and investment.- Current ratio: 4.02 - indicates strong short-term liquidity (4.02 times current liabilities).
- Quick ratio: 3.19 - shows ample liquid assets to cover immediate liabilities without relying on inventory conversions.
- Net cash position: 1.96 billion CNY - a substantial cash buffer versus debt.
- Operating cash flow (TTM): 708.89 million CNY - strong cash generation from core operations over the past 12 months.
- Free cash flow (TTM): 451.56 million CNY - healthy residual cash after capital expenditures.
- Interest coverage ratio: 158.59 - extremely comfortable ability to service interest expenses.
| Metric | Value | Unit / Notes |
|---|---|---|
| Current Ratio | 4.02 | Times |
| Quick Ratio | 3.19 | Times |
| Net Cash Position | 1,960,000,000 | CNY |
| Operating Cash Flow (TTM) | 708,890,000 | CNY |
| Free Cash Flow (TTM) | 451,560,000 | CNY |
| Interest Coverage Ratio | 158.59 | Times (EBIT/Interest) |
Micro-Tech Co., Ltd. (688029.SS) Valuation Analysis
This section breaks down key valuation metrics for Micro-Tech Co., Ltd. (688029.SS) to help investors gauge relative market pricing, profitability expectations, and balance-sheet backing.
- Trailing P/E: 24.09 - price paid today for historical earnings, indicating moderate premium versus peers with lower P/E.
- Forward P/E: 21.82 - market-implied earnings growth expectation; lower than trailing P/E suggests anticipated EPS expansion.
- P/S ratio: 4.70 - valuation relative to sales, signaling market willingness to pay ~4.7x annual revenue.
- P/B ratio: 3.46 - reflects the market pricing versus book value; above 1 indicates equity valued above net asset base.
- EV/EBITDA: 18.00 - enterprise-level valuation against operating cash-profit; useful for capital-structure-neutral comparisons.
- EV/Revenue: 4.13 - enterprise value per unit of revenue, aligning with P/S but capital-structure aware.
| Metric | Value | Interpretation |
|---|---|---|
| Trailing P/E | 24.09 | Moderate premium to historical earnings |
| Forward P/E | 21.82 | Market expects earnings growth |
| P/S | 4.70 | ~4.7x annual sales valuation |
| P/B | 3.46 | Company valued >3x book value |
| EV/EBITDA | 18.00 | Valuation relative to operating cash-profit |
| EV/Revenue | 4.13 | Enterprise valuation per unit revenue |
| Market Capitalization | 14.68 billion CNY | Equity market value |
| Enterprise Value (EV) | 12.89 billion CNY | Market cap adjusted for debt/cash |
- Relative strength: P/E and EV/EBITDA around mid-teens to high-teens suggest investors pay for growth expectations but should be checked against industry peers and historical ranges.
- Balance-sheet perspective: P/B of 3.46 implies equity market confidence above net asset backing; cross-check with ROE and asset composition.
- Revenue vs. enterprise value: EV/Revenue 4.13 and P/S 4.70 indicate consistent pricing whether using equity or enterprise metrics.
For additional investor context and ownership/transaction insights, see: Exploring Micro-Tech (Nanjing) Co., Ltd. Investor Profile: Who's Buying and Why?
Micro-Tech Co., Ltd. (688029.SS) - Risk Factors
Micro-Tech Co., Ltd. presents a mix of low market volatility, conservative leverage, and strong cash-generation metrics, but investors should weigh specific risk dimensions tied to valuation momentum, market exposure, and operational dependencies.
- Market volatility: beta = 0.15 - substantially lower than market average, implying limited share-price swings but also reduced upside during broad rallies.
- Price momentum: 52‑week price change = +8.89% - moderate appreciation; not a runaway growth story and may reflect sector- or stock-specific plateaus.
- Technical valuation signal: RSI = 40.01 - below the neutral 50, suggesting potential undervaluation or consolidation phase; watch for trend reversal or continuation signals.
- Interest servicing: interest coverage ratio = 158.59 - extremely robust ability to meet interest obligations; credit risk from interest expense is minimal.
- Leverage profile: debt-to-equity = 0.06 - very low financial leverage, limiting downside from debt stress but also signaling conservative capital structure that may constrain leverage-driven ROE lift.
- Cash efficiency: operating cash flow materially exceeds capital expenditures - indicates strong free cash flow generation and internal funding capacity for dividends, buybacks, or M&A.
| Metric | Value | Implication |
|---|---|---|
| Beta | 0.15 | Low volatility vs. market |
| 52‑Week Price Change | +8.89% | Moderate price appreciation |
| RSI | 40.01 | Potential undervaluation / consolidation |
| Interest Coverage Ratio | 158.59 | Very strong interest payment capacity |
| Debt-to-Equity | 0.06 | Minimal financial leverage |
| Operating Cash Flow vs. CapEx | OCF >> CapEx | Healthy free cash flow; efficient cash management |
- Concentration and growth risk: low leverage reduces bankruptcy risk but may indicate limited financial flexibility for rapid expansion compared with peer firms using moderate leverage.
- Market-return tradeoff: very low beta may limit upside capture in bullish cycles-investors seeking aggressive growth may find returns muted.
- Valuation timing: RSI near 40 and modest 52‑week gain suggest timing risk-entry points should consider both technical confirmations and fundamental catalysts.
- Operational dependencies: strong cash flow today does not immunize the company from supply‑chain disruptions, product-cycle shifts, or competitive pricing pressure that could compress margins.
- Event risk: despite strong interest coverage, unforeseen one‑off impairments, regulatory changes, or major capital projects could alter balance-sheet dynamics.
Further context on corporate background and strategy is available here: Micro-Tech (Nanjing) Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Micro-Tech Co., Ltd. (688029.SS) Growth Opportunities
Micro-Tech Co., Ltd. (688029.SS) demonstrates clear growth momentum driven by strong international expansion, product-line tailwinds in endoscopic consumables and oncology interventions, and improving profitability metrics that support continued reinvestment.- Overseas revenue growth: +30.4% year-over-year in 2024, signaling accelerated international traction.
- Regional diversification in 2024:
- Asia‑Pacific: +5.5% YoY
- Americas: +23.5% YoY
- EMEA (Europe, Middle East, Africa): +37.1% YoY
- Product-line growth in 2024:
- Endoscopic consumables: revenue +13.5% YoY
- Oncology interventions: revenue +19.1% YoY
- Gross margin expanded to 67.65% in 2024, up 3.15 percentage points versus the prior year.
- Operating cash flow substantially exceeds capital expenditures, indicating strong cash conversion and capacity to fund growth initiatives and R&D.
- Increased sales expense investment focused on both domestic and international market expansion to capture share across segments and geographies.
| Metric | 2024 | YoY Change |
|---|---|---|
| Overseas revenue growth | - | +30.4% |
| Asia‑Pacific revenue | - | +5.5% |
| Americas revenue | - | +23.5% |
| EMEA revenue | - | +37.1% |
| Endoscopic consumables revenue | - | +13.5% |
| Oncology interventions revenue | - | +19.1% |
| Gross margin | 67.65% | +3.15 pp |
| Operating cash flow vs. CapEx | Operating cash flow >> CapEx | Positive cash conversion |
- Strategic implications for investors:
- Diversified regional growth reduces single‑market risk and opens multiple expansion levers.
- Strong product-line growth (endoscopy and oncology) supports higher-margin revenue mix.
- Improved gross margin and excess operating cash flow provide flexibility for marketing/sales investments, M&A, and R&D.

Micro-Tech (Nanjing) Co., Ltd. (688029.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.